サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1753302

抗菌止血ジェルの世界市場

Antibacterial Hemostatic Gels

出版日
ページ情報
英文 290 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
抗菌止血ジェルの世界市場
出版日: 2025年06月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 290 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗菌止血ジェルの世界市場は2030年までに20億米ドルに到達

2024年に14億米ドルと推定される抗菌止血ジェルの世界市場は、分析期間2024-2030年にCAGR 5.5％で成長し、2030年には20億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである尿検査キットは、CAGR 6.6%を記録し、分析期間終了時には7億5,290万米ドルに達すると予測されます。血液学検査キット分野の成長率は、分析期間中CAGR 6.1%と推定されます。

米国市場は3億9,360万米ドルと推定、中国はCAGR 8.9％で成長予測

米国の抗菌止血ジェル市場は、2024年に3億9,360万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを8.9%として、2030年までに4億480万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と5.5%と予測されています。欧州では、ドイツがCAGR 3.6%で成長すると予測されています。

世界の抗菌止血ジェル市場- 主要動向と促進要因のまとめ

抗菌止血ジェルは創傷管理プロトコルをどのように変革しているか？

抗菌止血ジェルは、迅速な止血と感染制御という2つの重要な機能を併せ持つ画期的な創傷治療製品として台頭してきています。従来、創傷管理には、止血用と細菌繁殖防止用というように、複数のステップと別々の製品が必要でした。この新しいゲルは、オールインワンのソリューションを提供することで、そのような細分化の必要性をなくし、救急医療や外科医療を劇的に簡素化します。これらのジェルの背後にある技術は、多くの場合、血液を素早く吸収し、凝固メカニズムを活性化し、同時に抗菌剤を放出することで感染のリスクを軽減する天然または合成ポリマーに基づいています。特に、外傷、戦場での負傷、外科的処置、慢性創傷治療など、一刻を争う場面や感染リスクが高い場面で有用です。救急救命士やフィールド・メディックが、入院前の患者を迅速に安定させるために使用します。注射器やチューブで簡単に塗布できるため、非医療現場でも使いやすいです。臨床試験では、これらのゲルの一部は、広域抗菌効果を維持しながら、60秒以内に止血できることが示されています。さらに、全身的な抗生物質の必要性を減らすことができ、これは抗生物質耐性に関する懸念が高まる中、特に重要です。創傷管理プロトコルが進化するにつれ、抗菌止血ジェルのデュアルアクション機能は、外傷用キット、手術用パック、軍用医療用品に急速に組み込まれ、現代医療における出血と感染症への対処方法のパラダイムシフトを示唆しています。

この画期的な進歩を支えている科学的進歩とは？

抗菌止血ジェルの台頭は、多機能で生物活性のある化合物の開発を可能にした、バイオマテリアル科学とナノテクノロジーにおける飛躍的進歩によるところが大きいです。これらのゲルは通常、キトサン、ゼラチン、コラーゲンのようなバイオポリマー、あるいは身体の凝固系と積極的に相互作用する合成誘導体で構成されています。抗菌作用を高めるために、銀ナノ粒子、酸化亜鉛、その他の広域抗菌剤をゲルマトリックスに埋め込みます。pHの変化や細菌の活性など、特定の環境的な合図が検出されたときにのみ抗菌剤を放出する、生体応答性放出メカニズムを利用した製剤もあります。この精度は細胞毒性を軽減し、治療効率を高める。さらに、研究者たちは、標的抗菌特性を持つペプチドや酵素を組み込むようになり、バイオフィルムの形成を積極的に破壊し、MRSAや緑膿菌のような耐性菌株を抑制することができるようになりました。もうひとつの重要な開発は、トロンビンやフィブリノゲンといった天然の凝固因子を模倣した止血剤を組み込むことで、出血性疾患のある患者でも凝固を促進させることです。いくつかの製品は生分解性と再吸収性を持つように設計されており、除去の必要性をなくし、傷跡を最小限に抑えることができます。このような科学的革新は、単に製品の性能を向上させるだけでなく、戦場や救急医療から手術後の創傷管理、さらには歯科治療まで、潜在的な使用事例を拡大しつつあります。ゲルの粘度、組織接着性、熱安定性の継続的な改良は、従来の病院環境と移動式医療ユニットの両方での採用をさらに後押ししています。その結果、これらの技術革新は抗菌止血ジェルをより効果的なものにするだけでなく、より汎用性の高いものにし、医療の様々な分野への応用の道を開いています。

なぜヘルスケア業界はこのジェルを急速に採用しているのか？

ヘルスケア業界が抗菌止血ジェルを急速に採用したのは、臨床的ニーズ、経済的価値、規制上のサポートが融合したためと考えられます。病院、手術センター、外傷治療室は、コストを管理し、厳格な手続きスケジュールを守る一方で、感染率を下げ、患者の転帰を改善しなければならないという大きなプレッシャーにさらされています。これらのゲルは、創傷治療における最も重要な懸念事項である出血コントロールと感染予防の2つに同時に対処することで、非常に効率的なソリューションを提供します。この2つの機能により、患者1人あたりに使用する製品数が大幅に削減され、在庫が合理化され、治療費全体が削減されます。ワークフローの観点からは、ジェルの使いやすさと迅速な塗布により、手術の手技時間を短縮し、出血量の多い手術中の合併症のリスクを最小限に抑えることができます。その救命の可能性と証明された安全性プロファイルにより、多くのゲルが迅速承認を受けています。さらに、低侵襲手技の増加により、狭い解剖学的空間でも迅速かつ正確に適用できる製品への需要が生じています。公衆衛生システムもまた、災害への備えや緊急医療サービスにおける価値を認識しつつあります。各国政府は、特に自然災害や紛争に見舞われやすい国々で、国家外傷キットの一部としてこのジェルを備蓄し始めています。さらに、院内感染（HAI）に対する意識の高まりや抗菌薬スチュワードシップ政策の推進により、病院は総合的な創傷ケアソリューションを導入するようになっています。医療資源が限られている新興国では、このような多目的ジェルは、少ない備品と少ない専門トレーニングで効果的な創傷ケアを提供する効率的な方法です。抗菌止血ジェルの拡張性、効率性、臨床的汎用性により、ヘルスケア提供のあらゆる層で非常に魅力的なソリューションとなっています。

抗菌止血ジェルの市場成長を促進する主な要因は？

抗菌止血ジェル市場の成長は、技術の進歩、臨床プロトコルの変化、ヘルスケアの優先事項の進化に根ざしたいくつかの要因によってもたらされます。第一に、交通事故、産業事故、紛争地域などによる外傷の増加により、感染対策にもなる迅速対応の止血材製品への一貫した需要が生まれています。第二に、選択的手術と緊急手術の両方を含む世界の外科手術の増加により、病院や外来でのこれらのゲルの用途が拡大しています。第三に、抗生物質耐性という現在進行中の世界の課題により、臨床の焦点は局所的な抗菌ソリューションへとシフトしており、これらのゲルは感染制御を損なうことなく全身的な抗生物質の使用を減らす実行可能な方法を提供しています。第四に、バイオマテリアル工学の開発により、高い効果だけでなく、コスト効率が高く、さまざまな温度や環境条件下で安定したゲルの製造が可能になりました。第5に、軍事・戦術医療プログラムの拡大が極めて重要な役割を果たしており、世界中の国防省が兵士や衛生兵のためのフィールドキットにこれらのゲルを組み込んでいます。第6に、患者の嗜好が進化しており、より早く回復し、合併症のリスクが低く、痛みの少ない治療を求める人が増えています。第7に、外来診療所や在宅ヘルスケアサービスの成長により、使い勝手の良い多目的創傷ケア製品の需要が高い新たな流通チャネルが開拓されつつあります。最後に、ヘルスケア投資家からの強力なバックアップと、バイオテクノロジー企業と医療機関の研究開発協力が、製品のイノベーションと市場浸透を加速させています。これらの要因が相まって、抗菌止血ジェルは力強い成長軌道を描いており、先進国、開発途上国を問わず、現代的な創傷ケアに欠かせない要素として位置づけられています。

セグメント

製品（尿分析検査キット、血液学検査キット、血圧モニタリング装置、血糖モニタリング装置、その他製品）;エンドユース（在宅医療エンドユース、診断センターエンドユース、病院エンドユース、クリニックエンドユース、その他エンドユース）

調査対象企業の例（注目の41社）

  • 3M Company
  • Baxter International Inc.
  • BioTime, Inc.
  • C.R. Bard, Inc.（Becton Dickinson）
  • ConvaTec Group Plc
  • DePuy Synthes（Johnson & Johnson）
  • Fumedica AG
  • Haemonetics Corporation
  • HEMOTECH Biomed Pvt Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care
  • Novosorb Biodegradable Products
  • OMRON Corporation
  • Pfizer Inc.
  • Porcine Biotech
  • Smith & Nephew plc
  • Stryker Corporation
  • WoundCare Technologies

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36169

Global Antibacterial Hemostatic Gels Market to Reach US$2.0 Billion by 2030

The global market for Antibacterial Hemostatic Gels estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Urinanalysis Testing Kits, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$752.9 Million by the end of the analysis period. Growth in the Hematology Testing Kits segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$393.6 Million While China is Forecast to Grow at 8.9% CAGR

The Antibacterial Hemostatic Gels market in the U.S. is estimated at US$393.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$404.8 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Antibacterial Hemostatic Gels Market - Key Trends & Drivers Summarized

How Are Antibacterial Hemostatic Gels Transforming Wound Management Protocols?

Antibacterial hemostatic gels are emerging as a revolutionary class of wound care products that combine two critical functionalities-rapid hemostasis and infection control. Traditionally, wound management has required multiple steps and separate products: one for stopping bleeding, and another to prevent bacterial growth. These new gels eliminate the need for such segmentation by providing an all-in-one solution, drastically simplifying emergency and surgical care. The technology behind these gels is often based on natural or synthetic polymers that can rapidly absorb blood, activate clotting mechanisms, and simultaneously release antimicrobial agents to reduce the risk of infection. They are particularly useful in trauma cases, battlefield injuries, surgical procedures, and chronic wound care, where time is of the essence and infection risk is high. One of the most impactful applications of these gels is in pre-hospital emergency care, where paramedics and field medics can use them to stabilize patients quickly before hospital admission. Their ease of application-typically through a syringe or tube-makes them user-friendly even in non-medical settings. Clinical trials have shown that some of these gels can stop bleeding in under 60 seconds while maintaining broad-spectrum antibacterial efficacy. Furthermore, they reduce the need for systemic antibiotics, which is especially important in light of growing concerns around antibiotic resistance. As wound management protocols evolve, the dual-action functionality of antibacterial hemostatic gels is rapidly being integrated into trauma kits, surgical packs, and military medical supplies, signaling a paradigm shift in how bleeding and infection are addressed together in modern medicine.

What Are the Scientific Advancements Powering This Breakthrough?

The rise of antibacterial hemostatic gels is largely attributable to breakthroughs in biomaterials science and nanotechnology, which have enabled the development of multifunctional, bioactive compounds. These gels typically comprise biopolymers like chitosan, gelatin, collagen, or synthetic derivatives that interact positively with the body’s clotting system. To enhance antimicrobial action, silver nanoparticles, zinc oxide, or other broad-spectrum antibacterial agents are embedded into the gel matrix. Some formulations utilize bioresponsive release mechanisms-delivering the antibacterial agent only when certain environmental cues, such as pH change or bacterial activity, are detected. This precision reduces cytotoxicity and enhances therapeutic efficiency. Additionally, researchers have begun integrating peptides and enzymes with targeted antibacterial properties, which can actively disrupt biofilm formation and inhibit resistant bacterial strains such as MRSA and Pseudomonas aeruginosa. Another important development is the incorporation of hemostatic agents that mimic natural clotting factors, such as thrombin or fibrinogen, to accelerate coagulation even in patients with bleeding disorders. Several products are being engineered to be biodegradable and reabsorbable, which eliminates the need for removal and minimizes scarring. These scientific innovations are not just improving product performance but are also expanding the potential use cases-from battlefield and emergency care to post-operative surgical wound management and even dental procedures. The continuous refinement of gel viscosity, tissue adhesion, and thermal stability further supports their adoption in both traditional hospital settings and mobile medical units. As a result, these innovations are not only making antibacterial hemostatic gels more effective but also more versatile, opening up avenues for applications across multiple fields of medicine.

Why Is the Healthcare Industry Rapidly Adopting These Gels?

The healthcare industry’s swift embrace of antibacterial hemostatic gels can be attributed to a convergence of clinical need, economic value, and regulatory support. Hospitals, surgical centers, and trauma units are under immense pressure to reduce infection rates and improve patient outcomes while managing costs and adhering to stringent procedural timelines. These gels offer a highly efficient solution by addressing two of the most critical concerns in wound care simultaneously: bleeding control and infection prevention. This dual capability significantly reduces the number of products used per patient, streamlining inventory and lowering overall treatment costs. From a workflow perspective, the ease of use and rapid application of gels can reduce procedural times in surgeries and minimize the risk of complications during high-blood-loss operations. The adoption is further accelerated by favorable regulatory classifications in several countries, with many gels receiving expedited approvals due to their life-saving potential and proven safety profiles. Additionally, the rise in minimally invasive procedures has created demand for products that can be applied quickly and with precision in constrained anatomical spaces-something these gels are uniquely suited for. Public health systems are also recognizing their value in disaster preparedness and emergency medical services. Governments are beginning to stockpile these gels as part of national trauma kits, especially in countries prone to natural disasters or conflict. Furthermore, increasing awareness of hospital-acquired infections (HAIs) and the push toward antimicrobial stewardship policies are encouraging hospitals to adopt integrated wound care solutions. In emerging economies, where medical resources are limited, these multipurpose gels present an efficient way to deliver effective wound care with fewer supplies and less specialized training. The scalability, efficiency, and clinical versatility of antibacterial hemostatic gels make them a highly attractive solution across all tiers of healthcare delivery.

What Are the Key Factors Driving Market Growth for Antibacterial Hemostatic Gels?

The growth in the antibacterial hemostatic gels market is driven by several factors rooted in technological advancements, changing clinical protocols, and evolving healthcare priorities. First, the increasing incidence of traumatic injuries-whether from road accidents, industrial mishaps, or conflict zones-is creating consistent demand for rapid-response hemostatic products that also provide infection control. Second, the rise in surgical procedures worldwide, including both elective and emergency surgeries, is expanding the application base for these gels in hospitals and outpatient settings. Third, the ongoing global challenge of antibiotic resistance has shifted clinical focus toward localized antimicrobial solutions, and these gels offer a viable way to reduce systemic antibiotic use without compromising infection control. Fourth, improvements in biomaterial engineering have allowed for the production of gels that are not only highly effective but also cost-efficient and stable across different temperatures and environmental conditions, which is crucial for their use in both developed and resource-limited healthcare systems. Fifth, the expansion of military and tactical medicine programs is playing a pivotal role, with defense departments across the world integrating these gels into field kits for soldiers and medics. Sixth, patient preferences are evolving, with more people seeking treatments that promise faster recovery, lower complication risks, and less pain-factors that these gels directly address. Seventh, the growth of outpatient clinics and home healthcare services is opening new distribution channels where user-friendly, multi-purpose wound care products are in high demand. Lastly, strong backing from healthcare investors, along with R&D collaborations between biotech firms and medical institutions, is accelerating product innovation and market penetration. These drivers, in tandem, are creating a robust growth trajectory for antibacterial hemostatic gels, positioning them as an indispensable component of modern wound care across both advanced and developing healthcare systems.

SCOPE OF STUDY:

The report analyzes the Antibacterial Hemostatic Gels market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Other Products); End-Use (Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • 3M Company
  • Baxter International Inc.
  • BioTime, Inc.
  • C.R. Bard, Inc. (Becton Dickinson)
  • ConvaTec Group Plc
  • DePuy Synthes (Johnson & Johnson)
  • Fumedica AG
  • Haemonetics Corporation
  • HEMOTECH Biomed Pvt Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care
  • Novosorb Biodegradable Products
  • OMRON Corporation
  • Pfizer Inc.
  • Porcine Biotech
  • Smith & Nephew plc
  • Stryker Corporation
  • WoundCare Technologies

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Antibacterial Hemostatic Gels - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Surgical Volumes and Wound Management Needs Throw the Spotlight on Antibacterial Hemostatic Gels
    • Use in Trauma, Orthopedics, and Cardiac Surgeries Expands Market Relevance Across Specialties
    • OEMs Offering Dual-Action Hemostasis and Infection Control Enhance Surgical Efficiency
    • Growth in Emergency and Battlefield Medicine Drives Demand for Rapid-Action Gel Formulations
    • Use of Biocompatible Polymers and Silver-Based Agents Enhances Healing Outcomes
    • OEM Emphasis on Preloaded Syringes and Easy Applicators Improves OR Workflow
    • Rising Focus on Reducing Surgical Site Infections Drives Adoption of Antibacterial Technologies
    • Use in Robotic and Laparoscopic Procedures Promotes Precision Application
    • Expansion of Field Use in Remote and Resource-Limited Settings Supports Global Adoption
    • OEMs Integrating Hemostatic Gels With Advanced Wound Closure Systems Add Value to Surgical Kits
    • Use in Dental, ENT, and Neurosurgery Diversifies Clinical Use Cases
    • Growing Demand for Reabsorbable and Non-Animal-Sourced Formulations Broadens Patient Eligibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Antibacterial Hemostatic Gels Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Antibacterial Hemostatic Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urinanalysis Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urinanalysis Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Urinanalysis Testing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hematology Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hematology Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hematology Testing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Pressure Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Pressure Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Blood Pressure Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Antibacterial Hemostatic Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION